author-photo

Melinda L. Telli

Stanford University

178

Papers

6640

Citations

Citation Trend

Filter By

Papers (113) Sort By

Journal Conference Others

Neoadjuvant talazoparib (TALA) in patients (pts) with germline BRCA1/2 (gBRCA1/2) mutation-positive, early HER2-negative breast cancer (BC): Exploration of tumor BRCA mutational status and zygosity and overall mutational landscape in a phase 2 study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS17-22: Intratumoral delivery of tavokinogene telseplasmid (plasmid IL-12) and electroporation induces an immune signature that predicts successful combination in patients

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD10-12: Genomic analysis from the talazoparib beyond BRCA clinical trial: Homologous recombination (HR) deficiency scores, loss-of-heterozygosity and mutations in non-BRCA1/2 mutant tumors with other HR mutations

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Intratumoral plasmid IL-12 expands CD8+ T cells and induces a CXCR3 gene signature in triple-negative breast tumors that sensitizes patients to anti-PD-1 therapy.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
A phase II clinical trial of talazoparib monotherapy for PALB2 mutation-associated advanced breast cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.

2021 Journal of The National Comprehensive Cancer Network
Show All
- Source
- Cite
- Save
Citations (17)
BROCADE3: a challenge to the treatment paradigm in BRCA breast cancer?

2020 Lancet Oncology
- Melinda L. Telli
Show All
- Source
- Cite
- Save
Citations (0)
Breast cancer, version 3.2020

2020 Journal of The National Comprehensive Cancer Network
Show All
- Source
- Cite
- Save
Citations (72)
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)